Novartis Ag (NVSEF) FCF Margin Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) FCF Margin Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1,277.00
Jun 30, 2024 3,867.00
Dec 31, 2023 -16,353.00
Jun 30, 2023 132.00
Mar 31, 2023 -6,985.00
Dec 31, 2022 193,219.00
Sep 30, 2022 -10,531.00
Jun 30, 2022 -58.00
Dec 31, 2021 2,528.00
Sep 30, 2021 -8,159.00
Jun 30, 2021 -24,739.00
Mar 31, 2021 -20.37 Bn
Dec 31, 2020 173,823.00
Sep 30, 2020 -39,931,034.48 Bn
Jun 30, 2020 -31,674.00
Mar 31, 2020 -21,350.00
Jun 30, 2019 -67,552.00
Mar 31, 2019 -46,072.00
Jun 30, 2018 -12,210.00
Mar 31, 2018 7,134.00